gavel on top of a pile of bills and pills

Development and Delivery of Drug Pricing Policy

We know that drug pricing is a critical issue across the globe.

The Petrie-Flom Center, along with Global Access in Action at the Berkman Klein Center for Internet and Society at Harvard University, will host a conference featuring fresh ideas for solutions from patient advocates, industry insiders, academic thought leaders, and administration officials.

Join us to engage with panels and keynotes where speakers will lead novel, interdisciplinary discussions in an effort to better address current challenges both in the U.S. and globally.

Confirmed speakers include Ronald Piervincenzi (CEO of the United States Pharmacopeial Convention), Sean Dickson (of the Drug Spending Research Initiative at The Pew Charitable Trusts), Hannah Kettler (Senior Program Officer, Industry Leadership Engagement and Thinkubator Lead at the Bill & Melinda Gates Foundation), Joe GroganAssociate Director, Health Programs, Office of Management and Budget), and many more. 

For a full conference schedule and to register, please click here! 

 

 

Read more Bill of Health coverage of drug pricing and policy: 

The Rotten U.S. Antiparasitic Drug Market

Step therapy explained: An increasingly popular tool for cost control

Right to Try’s Problem is Funding, not Over-Regulation

Hits and misses from the Senate HELP Committee hearing on the President’s Blueprint for lower drug prices

World Trade Month: Trade’s impact on domestic drug prices

Alex Pearlman

Alex Pearlman

Alex is the Editor in Chief of Bill of Health. As a reporter and editor, Alex has focused on covering the intersection of science and technology policy and human rights. She holds a masters degree in Bioethics and Society from King's College London. Alex is also the Communications Manager at the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.